# Inuline Supplement in Patients With Irritable Bowel Syndrome

> **NCT03174561** · NA · UNKNOWN · sponsor: **SC Fiterman Pharma SRL** · enrollment: 50 (estimated)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Inuline, Choline and Silymarin
- **OTHER:** diet restriction

## Key facts

- **NCT ID:** NCT03174561
- **Lead sponsor:** SC Fiterman Pharma SRL
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-01
- **Primary completion:** 2018-02-28
- **Final completion:** 2018-04-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03174561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03174561, "Inuline Supplement in Patients With Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03174561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*